Physician profile
Derek J Luney
NPI 1679535363
$2,036.95
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,358 · 2020: $326 · 2021: $64.07 · 2022: $289.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $432.36 | 2019-2022 | |
| Amgen INC. | $409.86 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $167.24 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $126.22 | 2019-2022 | |
| Pfizer INC. | $76.84 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $75.84 | 2019-2020 | |
| Chiesi USA, INC. | $75.79 | 2019-2020 | |
| Abbott Laboratories | $70.53 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.25 | 2019-2022 | |
| Medtronic Vascular, INC. | $60.43 | 2019 | |
| Amarin Pharma, INC. | $57.11 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $50.93 | 2021 | |
| Portola Pharmaceuticals, LLC | $46.94 | 2019 | |
| Medtronic, INC. | $44.06 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $35.63 | 2019-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $35.61 | 2019 | |
| Astellas Pharma US INC | $33.27 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $31.64 | 2019 | |
| Irhythm Technologies, INC. | $30.54 | 2019 | |
| Bardy Diagnostics, INC. | $26.00 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $25.91 | 2019 | |
| Edwards Lifesciences Corporation | $23.24 | 2019 | |
| Nuwellis, INC. | $18.34 | 2019 | |
| Novo Nordisk INC | $15.37 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Luney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.